Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionSeacrest Wealth Management, Llc
Latest Disclosed Ownership6,446 shares
Latest Disclosed Value $ 898,430
Seacrest Wealth Management, Llc reports 1.03% increase in ownership of GILD / Gilead Sciences, Inc.

On April 15, 2026 - Seacrest Wealth Management, Llc filed a 13F-HR form disclosing ownership of 6,446 shares of Gilead Sciences, Inc. (CH:GILD) valued at $898,430 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 6,380 shares of Gilead Sciences, Inc.. This represents a change in shares of 1.03% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 6,446 66 1.03 898 13.24 0.0961
2026-01-12 2025-12-31 13F GILEAD SCIENCES COM 375558103 6,380 -6 -0.09 793 5.03 0.0803
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 6,386 -141 -2.16 755 4.43 0.0797
2025-07-11 2025-06-30 13F GILEAD SCIENCES COM 375558103 6,527 -54 -0.82 724 -1.90 0.0786
2025-04-11 2025-03-31 13F GILEAD SCIENCES COM 375558103 6,581 -311 -4.51 737 15.88 0.0835
2025-01-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 6,892 -60 -0.86 637 9.28 0.0669
2024-10-16 2024-09-30 13F GILEAD SCIENCES COM 375558103 6,952 -750 -9.74 583 10.23 0.0628
2024-07-22 2024-06-30 13F GILEAD SCIENCES COM 375558103 7,702 -1,748 -18.50 528 -23.70 0.0601
2024-04-18 2024-03-31 13F GILEAD SCIENCES COM 375558103 9,450 -682 -6.73 692 -18.01 0.0846
2024-01-18 2023-12-31 13F GILEAD SCIENCES COM 375558103 10,132 -283 -2.72 844 8.21 0.1043
2023-10-12 2023-09-30 13F GILEAD SCIENCES COM 375558103 10,415 -80 -0.76 780 -3.47 0.1014
2023-07-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 10,495 -3,994 -27.57 809 -32.78 0.1021
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 14,489 -2,336 -13.88 1,202 -16.76 0.1628
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 16,825 -6,013 -26.33 1,444 2.48 0.2072
2022-11-15 2022-09-30 13F GILEAD SCIENCES COM 375558103 22,838 5,024 28.20 1,409 27.97 0.2139
2022-08-09 2022-06-30 13F GILEAD SCIENCES COM 375558103 17,814 -1,246 -6.54 1,101 -2.82 0.1386
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM 375558103 19,060 9,396 97.23 1,133 61.40 0.1301
2022-02-11 2021-12-31 13F GILEAD SCIENCES COM 375558103 9,664 -998 -9.36 702 -5.77 0.0770
2021-11-16 2021-09-30 13F GILEAD SCIENCES COM 375558103 10,662 -501 -4.49 745 -3.12 0.0899
2021-08-12 2021-06-30 13F GILEAD SCIENCES COM 375558103 11,163 433 4.04 769 10.97 0.0927
2021-05-17 2021-03-31 13F GILEAD SCIENCES COM 375558103 10,730 1,384 14.81 693 27.16 0.0918
2021-02-09 2020-12-31 13F GILEAD SCIENCES COM 375558103 9,346 -5,101 -35.31 545 -40.31 0.0766
2020-11-12 2020-09-30 13F GILEAD SCIENCES COM 375558103 14,447 -836 -5.47 913 -22.36 0.1463
2020-07-27 2020-06-30 13F GILEAD SCIENCES COM 375558103 15,283 -4,118 -21.23 1,176 -18.90 0.2032
2020-05-13 2020-03-31 13F GILEAD SCIENCES COM 375558103 19,401 14,318 281.68 1,450 339.39 0.3116
2020-01-22 2019-12-31 13F GILEAD SCIENCES COM 375558103 5,083 -1,116 -18.00 330 -16.03 0.0553
2019-10-15 2019-09-30 13F GILEAD SCIENCES COM 375558103 6,199 94 1.54 393 -4.61 0.0736
2019-07-19 2019-06-30 13F GILEAD SCIENCES COM 375558103 6,105 257 4.39 412 8.42 0.0839
2019-05-10 2019-03-31 13F GILEAD SCIENCES COM 375558103 5,848 -455 -7.22 380 -3.55 0.0652
2019-02-13 2018-12-31 13F GILEAD SCIENCES COM 375558103 6,303 -1,478 -18.99 394 -34.44 0.0812
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM 375558103 7,781 2,852 57.86 601 72.21 0.1017
2018-08-03 2018-06-30 13F GILEAD SCIENCES COM 375558103 4,929 -283 -5.43 349 -11.20 0.0629
2018-04-20 2018-03-31 13F GILEAD SCIENCES COM 375558103 5,212 362 7.46 393 13.26 0.0721
2018-02-02 2017-12-31 13F GILEAD SCIENCES COM 375558103 4,850 4,850 347 0.0634
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.